World Journal of
Pharmaceutical and Life Sciences

PROSPECTIVE STUDY ON PHARMACOTHERAPEUTIC MANAGEMENT OF HYPERTENSION IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE HOSPITAL

C. Mohana*, G. Likhitha, A. K. Sridharan, M. Indira and M. Kishore Babu, K.R. Manasa Swapna

ABSTRACT

Background: Hypertension is an well-known risk factor for chronic kidney disease and end-stage renal disease. Chronic kidney disease cases have been increasing in worldwide and it is recognized as a global health burden. Aim: To study the pharmacotherapeutic management of hypertension in patients of chronic kidney disease at various stages. Methods: A Prospective study was carried out in department of Nephrology, SVIMS, Tirupathi. A sample size of 103 patients was participated in the study period. The patients were recruitment was done as per study protocol. The collected data was analyzed and expressed in percentages. Results and Discussion: In our study 41-60 years age patients were more 49 (47.5%) as compared to other age patients. Out of 103 patients male patients were more 72 (69.90%) as compared to female patients. In our study hemodialysis male patients were 36 more as compared to females. In our study one treatment regimen patients were more 66 as compared to other treatment regimen patients. Conclusion: Chronic kidney disease has been increasing in worldwide and it is recognized as a global health burden. Hypertension is an established risk factor for progression of chronic kidney disease and end-stage renal disease. The more support form physicians and health care professionals to normalize the blood pressure that reduce their cardiovascular and renal risk. Our findings indicate that early detection of CKD stage and its risk factors and continuous lifestyle plan and therapeutic intervention programmes could lower the development of CKD complications.

[Full Text Article]   [Download Certificate]